These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35394397)

  • 21. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further Investigations of the Effects of Anti-β
    Ho YC; Ahuja KDK; Adams MJ
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1128-1133. PubMed ID: 29121809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
    Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
    Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
    Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
    Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
    Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Anti-β2 glycoprotein1 antibody in Systemic Lupus Erythrematosus Patients.
    Kamal Eldin TM; Elsherif WT; Elgendy SS; Youssif MS; ElMelegy TT
    Egypt J Immunol; 2021 Oct; 28(4):185-194. PubMed ID: 34882367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus.
    Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW
    Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reevaluation of predictive value of ACL and anti-β2GP1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world.
    Deng X; Liu X
    Rheumatol Int; 2012 Dec; 32(12):3881-6. PubMed ID: 22193216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shedding of soluble glycoprotein VI is neither affected by animal-derived antibeta-2-glycoprotein 1 antibodies nor IgG fractions from patients with systemic lupus erythematosus.
    Ho YC; Ahuja KDK; Andrews RK; Adams MJ
    Blood Coagul Fibrinolysis; 2020 Jun; 31(4):258-263. PubMed ID: 32205472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
    Lackner KJ; von Landenberg C; Barlage S; Schmitz G
    Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of antiphospholipid antibodies by enzyme immunoassay and chemiluminescent methods in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data).
    Cheldieva FA; Reshetnyak TM; Cherkasova MV; Lila AM
    Klin Lab Diagn; 2021 Sep; 66(9):546-551. PubMed ID: 34543533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation.
    Campbell AL; Pierangeli SS; Wellhausen S; Harris EN
    Thromb Haemost; 1995 Mar; 73(3):529-34. PubMed ID: 7667838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome.
    Naranjo L; Stojanovich L; Djokovic A; Andreoli L; Tincani A; Maślińska M; Sciascia S; Infantino M; Garcinuño S; Kostyra-Grabczak K; Manfredi M; Regola F; Stanisavljevic N; Milanovic M; Saponjski J; Roccatello D; Cecchi I; Radin M; Benucci M; Pleguezuelo D; Serrano M; Shoenfeld Y; Serrano A
    Front Immunol; 2022; 13():957201. PubMed ID: 36172349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLE.
    Dziamski K; Sharmeen S; Banki K; Perl A
    Clin Immunol; 2020 May; 214():108388. PubMed ID: 32200114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.
    Proulle V; Furie RA; Merrill-Skoloff G; Furie BC; Furie B
    Blood; 2014 Jul; 124(4):611-22. PubMed ID: 24825863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
    Chen J; Sun S; Yan Q; Bao C; Fu Q
    Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.